Institute of Medical Science, University of Toronto, 1 King’s College Circle, Toronto, Ontario, M5S 1A8, Canada.
Arthritis Res Ther. 2011;13(5):R163. doi: 10.1186/ar3482. Epub 2011 Oct 12.
The diagnosis of ankylosing spondylitis is made from a combination of clinical features and the presence of radiographic evidence that may be detected only after many years of inflammatory back pain. It is not uncommon to have a diagnosis confirmed 5 to 10 years after the initial onset of symptoms. Development of a more-sensitive molecular imaging technology to detect structural changes in the joints would lead to earlier diagnosis and quantitative tracking of ankylosis progression. Progressive ankylosis (ank/ank) mice have a loss of function in the Ank gene, which codes for a regulator of PPi transport. In this study, we used these ank/ank mutant mice to assess a noninvasive, quantitative measure of joint ankylosis with near-infrared (NIR) molecular imaging in vivo.
Three age groups (8, 12, and 18 weeks) of ank/ank (15 mice) and wild-type littermates (12 +/+ mice) were assessed histologically and radiographically. Before imaging, OsteoSense 750 (bisphosphonate pamidronate) was injected i.v. Whole-body images were analyzed by using the multispectral Maestro imaging system.
OsteoSense 750 signals in the paw joints were higher in ank/ank mice in all three age groups compared with controls. In the spine, significantly higher OsteoSense 750 signals were detected early, in 8-week-old ank/ank mice compared with controls, although minimal radiographic differences were noted at this time point. The molecular imaging changes in the ank/ank spine (8 weeks) were supported by histologic changes, including calcium apatite crystals at the edge of the vertebral bodies and new syndesmophyte formation.
Changes in joint pathology of ank/ank mice, as evaluated by histologic and radiographic means, are qualitative, but only semiquantitative. In contrast, molecular imaging provides a quantitative assessment. Ankylosis in ank/ank mice developed simultaneously in distal and axial joints, contrary to the previous notion that it is a centripetal process. NIR imaging might be feasible for early disease diagnosis and for monitoring disease progression in ankylosing spondylitis.
强直性脊柱炎的诊断是基于临床特征和放射学证据的综合判断,而这些证据可能要在经历多年炎性背痛后才能被发现。症状出现后 5 到 10 年才确诊的情况并不少见。如果能开发出一种更灵敏的分子成像技术来检测关节的结构变化,就能更早地诊断出疾病,并对强直性脊柱炎的进展进行定量跟踪。在 ank/ank 突变鼠中,编码焦磷酸(PPi)转运调节剂的 Ank 基因失去了功能。在本研究中,我们使用这些 ank/ank 突变鼠,通过体内近红外(NIR)分子成像技术,对关节强直进行了一种非侵入性的、定量的评估。
我们对 3 组年龄(8 周、12 周和 18 周)的 ank/ank 突变鼠(15 只)和野生型同窝鼠(12 只)进行了组织学和影像学评估。在成像之前,将双膦酸盐帕米膦酸盐(OsteoSense 750)经静脉注入体内。使用多光谱 Maestro 成像系统对全身图像进行分析。
与对照组相比,所有 3 组年龄的 ank/ank 鼠的爪关节中的 OsteoSense 750 信号都更高。在脊柱中,与对照组相比,8 周大的 ank/ank 鼠的 OsteoSense 750 信号更早、更显著,但此时仅在放射学上观察到微小差异。ank/ank 鼠脊柱(8 周)的分子成像变化得到了组织学变化的支持,包括椎体边缘的钙磷灰石晶体和新的骨桥形成。
通过组织学和影像学评估,ank/ank 鼠关节病变的变化是定性的,但只是半定量的。相比之下,分子成像提供了一种定量评估。ank/ank 鼠的强直在四肢和脊柱关节同时发生,这与之前认为它是一种向心性过程的观点相反。近红外成像可能可用于早期疾病诊断和监测强直性脊柱炎的疾病进展。